{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:15:25Z","timestamp":1792707325272,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010418","name":"Institute for Information and Communications Technology Promotion","doi-asserted-by":"publisher","award":["IITP-2025\\u20132020\\u20130\\u201301808"],"award-info":[{"award-number":["IITP-2025\\u20132020\\u20130\\u201301808"]}],"id":[{"id":"10.13039\/501100010418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HR22C1832"],"award-info":[{"award-number":["HR22C1832"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024\\u201300437643"],"award-info":[{"award-number":["RS-2024\\u201300437643"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2024\\u201300334982"],"award-info":[{"award-number":["RS-2024\\u201300334982"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019403","name":"Information Technology Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asia-Pacific Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.apjo.2025.100262","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:51:09Z","timestamp":1762573869000},"page":"100262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["International consensuses and guidelines on management of proliferative diabetic retinopathy (PDR) by the Asia-Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI)"],"prefix":"10.1016","volume":"14","author":[{"given":"Robert F.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant V.","family":"Radke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco M.","family":"Bandello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Bhende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemmy C.M.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian T.","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Y.W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer I.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Mieler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onnisa","family":"Nanegrungsunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paisan","family":"Ruamviboonsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.C.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apjo.2025.100262_bib1","first-page":"786","article-title":"ETDRS report number 10","volume":"98","author":"Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification","year":"1991"},{"key":"10.1016\/j.apjo.2025.100262_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2023.100002","article-title":"Prevalence and causes of vision impairment in elderly Chinese people living in suburban Shanghai","volume":"13","author":"Chen","year":"2024","journal-title":"Asia Pac J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib3","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2025.100262_bib4","unstructured":"Diabetic Retinopathy PPP 2024 - American Academy of Ophthalmology [Internet]. Cited June 8, 2025. Available from: \u3008https:\/\/www.aao.org\/education\/preferred-practice-pattern\/diabetic-retinopathy-ppp\u3009."},{"key":"10.1016\/j.apjo.2025.100262_bib5","article-title":"Current research and future strategies for the management of vision-threatening diabetic retinopathy","volume":"13","author":"Li","year":"2024","journal-title":"Asia Pac J Ophthalmol (Philos"},{"key":"10.1016\/j.apjo.2025.100262_bib6","article-title":"Consensus and guidelines on diagnosis and management of polypoidal choroidal vasculopathy (PCV) from the Asia-Pacific Vitreo-retina Society (APVRS)","volume":"14","author":"Ruamviboonsuk","year":"2025","journal-title":"Asia Pac J Ophthalmol (Philos"},{"key":"10.1016\/j.apjo.2025.100262_bib7","unstructured":"272-diabetic-retinopathy-grading.pdf [Internet]. Cited June 8, 2025. Available from: \u3008https:\/\/rightdecisions.scot.nhs.uk\/media\/2619\/272-diabetic-retinopathy-grading.pdf\u3009."},{"key":"10.1016\/j.apjo.2025.100262_bib8","unstructured":"NHS Diabetic Eye Screening Programme: grading definitions for referable disease - GOV.UK [Internet]. Cited June 8, 2025. Available from: \u3008https:\/\/www.gov.uk\/government\/publications\/diabetic-eye-screening-retinal-image-grading-criteria\/nhs-diabetic-eye-screening-programme-grading-definitions-for-referable-disease-start-date-october-01\u3009."},{"key":"10.1016\/j.apjo.2025.100262_bib9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1464-5491.2003.01077.x","article-title":"Grading and disease management in national screening for diabetic retinopathy in England and Wales","volume":"20","author":"Harding","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.apjo.2025.100262_bib10","first-page":"1796","article-title":"Early Treatment Diabetic Retinopathy Study report number 1","volume":"103","author":"Photocoagulation for diabetic macular edema","year":"1985"},{"key":"10.1016\/j.apjo.2025.100262_bib11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archopht.125.4.469","article-title":"Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema","volume":"125","author":"Writing Committee for the Diabetic Retinopathy Clinical Research Network","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib12","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema","volume":"121","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2025.100262_bib13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ophtha.2010.02.031","article-title":"Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Elman","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2025.100262_bib14","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","article-title":"Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE","volume":"120","author":"Brown","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2025.100262_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1079217","article-title":"Classification of diabetic retinopathy: Past, present and future","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.apjo.2025.100262_bib16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/APO.0000000000000583","article-title":"Application of artificial intelligence in precision medicine for diabetic macular edema","volume":"12","author":"Li","year":"2023","journal-title":"Asia Pac J Ophthalmol (Philos"},{"key":"10.1016\/j.apjo.2025.100262_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/APO.0000000000000584","article-title":"Recent advances in clinical applications of imaging in retinal diseases","volume":"12","author":"Szeto","year":"2023","journal-title":"Asia Pac J Ophthalmol (Philos"},{"key":"10.1016\/j.apjo.2025.100262_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/IAE.0000000000004510","article-title":"Diabetic retinopathy phenotypes on ultrawide field retinal imaging in an Indian population","author":"Cherian","year":"2025","journal-title":"Retina"},{"key":"10.1016\/j.apjo.2025.100262_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaophthalmol.2018.4982","article-title":"Comparison of early treatment diabetic retinopathy study standard 7-field imaging with ultrawide-field imaging for determining severity of diabetic retinopathy","volume":"137","author":"Aiello","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib20","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1038\/s41433-023-02445-8","article-title":"Comparison of diabetic retinopathy severity grading on ETDRS 7-field versus ultrawide-field assessment","volume":"37","author":"Attiku","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.apjo.2025.100262_bib21","article-title":"Artificial intelligence for retinal diseases","volume":"13","author":"Lim","year":"2024","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"key":"10.1016\/j.apjo.2025.100262_bib22","article-title":"Latest developments of generative artificial intelligence and applications in ophthalmology","volume":"13","author":"Feng","year":"2024","journal-title":"Asia Pac J Ophthalmol (Philos)"},{"key":"10.1016\/j.apjo.2025.100262_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233514","article-title":"A convolutional neural network for the screening and staging of diabetic retinopathy","volume":"15","author":"Shaban","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.apjo.2025.100262_bib24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00592-023-02122-y","article-title":"Convolutional neural network-based sea lion optimization algorithm for the detection and classification of diabetic retinopathy","volume":"60","author":"Hemanth","year":"2023","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.apjo.2025.100262_bib25","article-title":"Diabetic retinopathy fundus image classification and lesions localization system using deep learning","volume":"21","author":"Alyoubi","year":"2021","journal-title":"Sens (Basel)"},{"key":"10.1016\/j.apjo.2025.100262_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/112067210701700112","article-title":"Clinical biomicroscopy versus fluorescein angiography: effectiveness and sensitivity in detecting diabetic retinopathy","volume":"17","author":"Khalaf","year":"2007","journal-title":"Eur J Ophthalmol"},{"issue":"Pt 5","key":"10.1016\/j.apjo.2025.100262_bib27","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/eye.2001.192","article-title":"Effectiveness of optometrist screening for diabetic retinopathy using slit-lamp biomicroscopy","volume":"15","author":"Prasad","year":"2001","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.apjo.2025.100262_bib28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1464-5491.2003.00969.x","article-title":"A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy","volume":"20","author":"Olson","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.apjo.2025.100262_bib29","first-page":"807","article-title":"ETDRS report number 11","volume":"98","author":"Classification of diabetic retinopathy from fluorescein angiograms","year":"1991"},{"key":"10.1016\/j.apjo.2025.100262_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.18240\/ijo.2022.02.11","article-title":"Comparison of fundus fluorescein angiography and fundus photography grading criteria for early diabetic retinopathy","volume":"15","author":"Li","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib31","first-page":"1344","volume":"105","author":"Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial","year":"1987"},{"key":"10.1016\/j.apjo.2025.100262_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jfo.2017.05.010","article-title":"Comparison of digital color fundus imaging and fluorescein angiographic findings for the early detection of diabetic retinopathy in young type 1 diabetic patients","volume":"41","author":"Kapsala","year":"2018","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/ceo.12711","article-title":"Contemporary retinal imaging techniques in diabetic retinopathy: a review","volume":"44","author":"Cole","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1442-9071.2006.01136.x","article-title":"Fluorescein angiography and adverse drug reactions revisited: the Lions Eye experience","volume":"34","author":"Kwan","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40942-017-0062-2","article-title":"Diabetic retinopathy and OCT angiography: clinical findings and future perspectives","volume":"3","author":"de Barros Garcia","year":"2017","journal-title":"Int J Retin Vitr"},{"key":"10.1016\/j.apjo.2025.100262_bib36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2147\/OPTH.S133637","article-title":"Ultra-wide-field fluorescein angiography in diabetic retinopathy: a narrative review","volume":"11","author":"Rabiolo","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib37","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1007\/s00417-020-04847-w","article-title":"The prognostic value of peripheral retinal nonperfusion in diabetic retinopathy using ultra-widefield fluorescein angiography","volume":"258","author":"Antaki","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/bjophthalmol-2011-300774","article-title":"Peripheral retinal ischaemia, as evaluated by ultra-widefield fluorescein angiography, is associated with diabetic macular oedema","volume":"96","author":"Wessel","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib39","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2022.3130","article-title":"Association of ultra-widefield fluorescein angiography-identified retinal nonperfusion and the risk of diabetic retinopathy worsening over time","volume":"140","author":"Silva","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3928\/23258160-20190129-04","article-title":"Quantification of retinal nonperfusion associated with posterior segment neovascularization in diabetic retinopathy using ultra-widefield fluorescein angiography","volume":"50","author":"Baxter","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"10.1016\/j.apjo.2025.100262_bib41","first-page":"1846","article-title":"Modern approach to diabetic retinopathy diagnostics","volume":"14","author":"K\u0105pa","year":"2024","journal-title":"Diagn (Basel)"},{"key":"10.1016\/j.apjo.2025.100262_bib42","article-title":"Deep learning for automated detection of neovascular leakage on ultra-widefield fluorescein angiography in diabetic retinopathy","volume":"13","author":"Py","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.apjo.2025.100262_bib43","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.oret.2021.01.013","article-title":"Detection of diabetic retinopathy from ultra-widefield scanning laser ophthalmoscope images: a multicenter deep learning analysis","volume":"5","author":"Tang","year":"2021","journal-title":"Ophthalmol Retin"},{"key":"10.1016\/j.apjo.2025.100262_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000499114","article-title":"Comparison between findings in optical coherence tomography angiography and in fluorescein angiography in patients with diabetic retinopathy","volume":"243","author":"Enders","year":"2020","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.apjo.2025.100262_bib45","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.4103\/ijo.IJO_1267_21","article-title":"Role of optical coherence tomography-angiography in diabetes mellitus: Utility in diabetic retinopathy and a comparison with fluorescein angiography in vision threatening diabetic retinopathy","volume":"69","author":"Shaikh","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.12.7.13","article-title":"Inter-rater reliability of proliferative diabetic retinopathy assessment on wide-field OCT-angiography and fluorescein angiography","volume":"12","author":"Shah","year":"2023","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.apjo.2025.100262_bib47","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s00417-020-04773-x","article-title":"Wide-field optical coherence tomography angiography for the detection of proliferative diabetic retinopathy","volume":"258","author":"Pichi","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00417-022-05878-1","article-title":"Wide-field swept-source OCT angiography (23\u2009\u00d7\u200920 mm) for detecting retinal neovascularization in eyes with proliferative diabetic retinopathy","volume":"261","author":"Hirano","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib49","unstructured":"American Academy of Ophthalmology [Internet]. Diabetic Retinopathy PPP 2024. Published 2025. Cited 2025 June 9, 2025. Available from: \u3008https:\/\/www.aao.org\/education\/preferred-practice-pattern\/diabetic-retinopathy-ppp\u3009."},{"key":"10.1016\/j.apjo.2025.100262_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12938-017-0414-z","article-title":"Automatic non-proliferative diabetic retinopathy screening system based on color fundus image","volume":"16","author":"Xiao","year":"2017","journal-title":"Biomed Eng Online"},{"issue":"1","key":"10.1016\/j.apjo.2025.100262_bib51","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.21101\/cejph.a7838","article-title":"Diabetes mellitus and its influence on the incidence and process of diabetic retinopathy","volume":"31","author":"Por\u00e1\u010dov\u00e1","year":"2023","journal-title":"Cent Eur J Public Health"},{"key":"10.1016\/j.apjo.2025.100262_bib52","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/dme.13908","article-title":"Incidence of sight-threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review","volume":"36","author":"Groeneveld","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/j.apjo.2025.100262_bib53","article-title":"Risk factors for diabetic retinopathy, diabetic macular edema, and sight-threatening diabetic retinopathy","volume":"13","author":"Zhang","year":"2024","journal-title":"Asia Pac J Ophthalmol (Philos"},{"key":"10.1016\/j.apjo.2025.100262_bib54","doi-asserted-by":"crossref","first-page":"7853","DOI":"10.1038\/s41598-025-91941-w","article-title":"Creating a retinal image database to develop an automated screening tool for diabetic retinopathy in India","volume":"15","author":"Rajalakshmi","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.apjo.2025.100262_bib55","first-page":"1","article-title":"Leveraging artificial intelligence for diabetic retinopathy screening and management: history and current advances","author":"Rajalakshmi","year":"2024","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib56","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41591-024-03139-8","article-title":"Integrated image-based deep learning and language models for primary diabetes care","volume":"30","author":"Li","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.apjo.2025.100262_bib57","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41591-023-02702-z","article-title":"A deep learning system for predicting time to progression of diabetic retinopathy","volume":"30","author":"Dai","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.apjo.2025.100262_bib58","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/bjo.2007.120659","article-title":"Analysis of a comprehensive diabetic retinopathy screening model for rural and urban diabetics in developing countries","volume":"91","author":"Rani","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib59","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2147\/OPTH.S301317","article-title":"Management of patients with newly diagnosed diabetic mellitus: ophthalmologic outcomes in intensive versus conventional glycemic control","volume":"15","author":"Lam","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib60","article-title":"Developing a risk stratification model based on machine learning for targeted screening of diabetic retinopathy in the indian population","volume":"15","author":"Surya","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.apjo.2025.100262_bib61","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s13300-019-0652-0","article-title":"An evaluation system of fundus photograph-based intelligent diagnostic technology for diabetic retinopathy and applicability for research","volume":"10","author":"Yang","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.apjo.2025.100262_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198551","article-title":"Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives","volume":"13","author":"Bursell","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.apjo.2025.100262_bib63","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/aos.17428","article-title":"Evaluating the efficacy of AI systems in diabetic retinopathy detection: a comparative analysis of Mona DR and IDx-DR","volume":"103","author":"Grzybowski","year":"2025","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib64","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2589-7500(19)30004-4","article-title":"Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study","volume":"1","author":"Bellemo","year":"2019","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.apjo.2025.100262_bib65","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12913-022-07655-6","article-title":"Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.apjo.2025.100262_bib66","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1590\/1516-3180.2021.0713.r1.22022022","article-title":"Use of artificial intelligence in ophthalmology: a narrative review","volume":"140","author":"Martins","year":"2022","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.apjo.2025.100262_bib67","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41433-021-01912-4","article-title":"Comparison of early diabetic retinopathy staging in asymptomatic patients between autonomous AI-based screening and human-graded ultra-widefield colour fundus images","volume":"36","author":"Sedova","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.apjo.2025.100262_bib68","first-page":"583","article-title":"Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8","volume":"88","author":"Photocoagulation treatment of proliferative diabetic retinopathy","year":"1981"},{"key":"10.1016\/j.apjo.2025.100262_bib69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/2474126419893829","article-title":"American society of retina specialists clinical practice guidelines on the management of nonproliferative and proliferative diabetic retinopathy without diabetic macular edema","volume":"4","author":"Yonekawa","year":"2020","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.apjo.2025.100262_bib70","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.3390\/jcm9113772","article-title":"Effect of intravitreal bevacizumab injection before panretinal photocoagulation on the prevention of macular edema aggravation in proliferative diabetic retinopathy","volume":"9","author":"Choi","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.apjo.2025.100262_bib71","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/IAE.0b013e318042d32c","article-title":"Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy: a literature review","volume":"27","author":"Fong","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.apjo.2025.100262_bib72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08820530802519899","article-title":"Ultra wide field fluorescein angiography guided targeted retinal photocoagulation (TRP)","volume":"24","author":"Reddy","year":"2009","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1108394","article-title":"Advances in targeted retinal photocoagulation in the treatment of diabetic retinopathy","volume":"14","author":"Lin","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.apjo.2025.100262_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10633-021-09848-6","article-title":"Proliferative diabetic retinopathy treated with intravitreal ranibizumab and photocoagulation directed at ischemic retinal areas-A randomized study","volume":"143","author":"Toscano","year":"2021","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib75","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ophtha.2017.11.026","article-title":"Targeted retinal photocoagulation for diabetic macular edema with peripheral retinal nonperfusion: three-year randomized DAVE trial","volume":"125","author":"Brown","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2025.100262_bib76","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10792-017-0469-7","article-title":"Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial","volume":"38","author":"Nikkhah","year":"2018","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib77","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1167\/iovs.14-14682","article-title":"The effect of photocoagulation in ischemic areas to prevent recurrence of diabetic macular edema after intravitreal bevacizumab injection","volume":"55","author":"Takamura","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.apjo.2025.100262_bib78","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/bjophthalmol-2012-302189","article-title":"Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study","volume":"97","author":"Muqit","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib79","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.eye.6702725","article-title":"Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy","volume":"22","author":"Luttrull","year":"2008","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.apjo.2025.100262_bib80","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1007\/s10103-022-03635-8","article-title":"Comparison of functional changes of retina after subthreshold and threshold pan-retinal photocoagulation in severe non-proliferative diabetic retinopathy","volume":"37","author":"Zhao","year":"2022","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.apjo.2025.100262_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202347","article-title":"Development of diabetic retinopathy after cataract surgery","volume":"13","author":"Jeng","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.apjo.2025.100262_bib82","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/ojo.ojo_292_22","article-title":"Progression of diabetic retinopathy following uncomplicated phacoemulsification: a prospective study from South India","volume":"17","author":"Sruthi","year":"2024","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib83","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jcrs.2008.02.019","article-title":"Management of type 2 diabetics requiring panretinal photocoagulation and cataract surgery","volume":"34","author":"Suto","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.apjo.2025.100262_bib84","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","volume":"389","author":"Sivaprasad","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.apjo.2025.100262_bib85","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Writing Committee for the Diabetic Retinopathy Clinical Research NetworkGross","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.apjo.2025.100262_bib86","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","article-title":"Five-year outcomes of panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"136","author":"Gross","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib87","article-title":"Updates on medical and surgical managements of diabetic retinopathy and maculopathy","volume":"14","author":"Chen","year":"2025","journal-title":"AsiaPac J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib88","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00592-020-01548-y","article-title":"Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study","volume":"57","author":"Chatziralli","year":"2020","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.apjo.2025.100262_bib89","unstructured":"DRCR Retina Network - Public Site [Internet]. Cited June 10, 2025. Available from: \u3008https:\/\/public.jaeb.org\/drcrnet\/stdy\/607\u3009."},{"key":"10.1016\/j.apjo.2025.100262_bib90","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/APO.0000000000000602","article-title":"Review on the safety and efficacy of brolucizumab for neovascular age-related macular degeneration from major studies and real-world data","volume":"12","author":"Radke","year":"2023","journal-title":"Asia Pac J Ophthalmol (Philos"},{"key":"10.1016\/j.apjo.2025.100262_bib91","first-page":"1064","article-title":"Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Elman","year":"2010"},{"key":"10.1016\/j.apjo.2025.100262_bib92","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaophthalmol.2019.5939","article-title":"Visual field changes over 5 years in patients treated with panretinal photocoagulation or ranibizumab for proliferative diabetic retinopathy","volume":"138","author":"Maguire","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib93","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1159\/000512296","article-title":"Subthreshold pan-retinal photocoagulation using endpoint management algorithm for severe nonproliferative diabetic retinopathy: a paired controlled pilot prospective study","volume":"64","author":"Lai","year":"2021","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.apjo.2025.100262_bib94","first-page":"766","article-title":"ETDRS report number 9","volume":"98","author":"Early photocoagulation for diabetic retinopathy","year":"1991"},{"key":"10.1016\/j.apjo.2025.100262_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19510","article-title":"Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation","volume":"19","author":"Royle","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.apjo.2025.100262_bib96","article-title":"Combined use of anti-VEGF drugs before and during pars plana vitrectomy for severe proliferative diabetic retinopathy","volume":"12","author":"X","year":"2023","journal-title":"Ophthalmol Ther [Internet]"},{"key":"10.1016\/j.apjo.2025.100262_bib97","article-title":"Evaluation of intravitreal ranibizumab on the surgical outcome for diabetic retinopathy with tractional retinal detachment","volume":"95","author":"Dong","year":"2016","journal-title":"Med (Baltim)"},{"key":"10.1016\/j.apjo.2025.100262_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1067670","article-title":"Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: a randomized controlled trial","volume":"10","author":"Qu","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.apjo.2025.100262_bib99","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212532","article-title":"The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy","volume":"7","author":"Zhao","year":"2018","journal-title":"Drugs Context"},{"key":"10.1016\/j.apjo.2025.100262_bib100","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/eye.2017.75","article-title":"Ranibizumab pretreatment in diabetic vitrectomy: a pilot randomised controlled trial (the RaDiVit study)","volume":"31","author":"Comyn","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.apjo.2025.100262_bib101","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","article-title":"Five-year outcomes of panretinal photocoagulation vs intravitreous Ranibizumab for proliferative diabetic retinopathy","volume":"136","author":"Gross","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib102","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1001\/jamaophthalmol.2017.0837","article-title":"Cost-effectiveness of intravitreous ranibizumab compared with panretinal photocoagulation for proliferative diabetic retinopathy: secondary analysis from a diabetic retinopathy clinical research network randomized clinical trial","volume":"135","author":"Hutton","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib103","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fphar.2020.00849","article-title":"Anti-vascular endothelial growth factor therapy as an alternative or adjunct to pan-retinal photocoagulation in treating proliferative diabetic retinopathy: meta-analysis of randomized trials","volume":"11","author":"Gao","year":"2020","journal-title":"Front Pharm"},{"key":"10.1016\/j.apjo.2025.100262_bib104","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.ophtha.2009.07.001","article-title":"Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial","volume":"116","author":"Ahmadieh","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2025.100262_bib105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00417-008-0774-y","article-title":"Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)","volume":"246","author":"Rizzo","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib106","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.ophtha.2011.03.036","article-title":"The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy","volume":"118","author":"Ahn","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.apjo.2025.100262_bib107","article-title":"Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy","volume":"2015","author":"Smith","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.apjo.2025.100262_bib108","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12886-020-01532-8","article-title":"Multiple factors in the prediction of risk of recurrent vitreous haemorrhage after sutureless vitrectomy for non-clearing vitreous haemorrhage in patients with diabetic retinopathy","volume":"20","author":"Ding","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib109","article-title":"xin. Perioperative anti-vascular endothelial growth factor agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: a network meta-analysis","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apjo.2025.100262_bib110","article-title":"Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: a review","volume":"66","author":"Y","year":"2021","journal-title":"Surv Ophthalmol [Internet]"},{"key":"10.1016\/j.apjo.2025.100262_bib111","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/jcm8111960","article-title":"Incidence and risk factors for tractional macular detachment after anti-vascular endothelial growth factor agent pretreatment before vitrectomy for complicated proliferative diabetic retinopathy","volume":"8","author":"Russo","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.apjo.2025.100262_bib112","article-title":"Comparative efficacy and safety of different anti-VEGF agents combined with different delivery methods for neovascular glaucoma: a systematic review and Bayesian network meta-analysis","volume":"14","author":"Wang","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.apjo.2025.100262_bib113","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3341\/kjo.2007.21.4.208","article-title":"Efficacy of intravitreal triamcinolone acetonide for eyes with postvitrectomy diabetic vitreous hemorrhage","volume":"21","author":"Lee","year":"2007","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib114","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/bjophthalmol-2021-320332","article-title":"Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy","volume":"107","author":"Liao","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00006982-200602000-00002","article-title":"Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema","volume":"26","author":"Zein","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.apjo.2025.100262_bib116","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/B:INTE.0000031740.85124.78","article-title":"Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone. Regression of diabetic optic disc neovascularization after intravitreal triamcinolone","volume":"25","author":"Karacorlu","year":"2004","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib117","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jamaophthalmol.2013.4154","article-title":"Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial","volume":"131","author":"Bressler","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.apjo.2025.100262_bib118","article-title":"Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the \u201cDR-Pro-DEX Study","volume":"55","author":"M","year":"2018","journal-title":"Acta Diabetol [Internet]"},{"key":"10.1016\/j.apjo.2025.100262_bib119","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/jop.2020.0079","article-title":"Effectiveness and safety of coadministration of intravitreal dexamethasone implant and silicone oil endotamponade for proliferative diabetic retinopathy with tractional diabetic macular edema","volume":"37","author":"Altun","year":"2021","journal-title":"J Ocul Pharm Ther"},{"key":"10.1016\/j.apjo.2025.100262_bib120","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2147\/DMSO.S445607","article-title":"The anatomic and functional outcomes of ozurdex-aided vitrectomy in proliferative diabetic retinopathy","volume":"17","author":"Wang","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.apjo.2025.100262_bib121","first-page":"1064","article-title":"Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema","volume":"117","author":"Elman","year":"2010"},{"key":"10.1016\/j.apjo.2025.100262_bib122","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2020.23027","article-title":"Effect of intravitreous aflibercept vs vitrectomy with panretinal photocoagulation on visual acuity in patients with vitreous hemorrhage from proliferative diabetic retinopathy: a randomized clinical trial","volume":"324","author":"Antoszyk","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.apjo.2025.100262_bib123","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/IAE.0000000000000622","article-title":"Effect of internal limiting membrane peeling during vitrectomy for diabetic macular edema: systematic review and meta-analysis","volume":"35","author":"Nakajima","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.apjo.2025.100262_bib124","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/IAE.0000000000001280","article-title":"Pars plana vitrectomy for diabetic macular edema: a systematic review, meta-analysis, and synthesis of safety literature","volume":"37","author":"Jackson","year":"2017","journal-title":"Retina"}],"container-title":["Asia-Pacific Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216209892500129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216209892500129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:50:40Z","timestamp":1773877840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216209892500129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":124,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S216209892500129X"],"URL":"https:\/\/doi.org\/10.1016\/j.apjo.2025.100262","relation":{},"ISSN":["2162-0989"],"issn-type":[{"value":"2162-0989","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International consensuses and guidelines on management of proliferative diabetic retinopathy (PDR) by the Asia-Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI)","name":"articletitle","label":"Article Title"},{"value":"Asia-Pacific Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apjo.2025.100262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Asia-Pacific Academy of Ophthalmology and Academy of Asia-Pacific Professors of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100262"}}